Haixing Bio-Tech

Haixing Bio-Tech is a specialized biotechnology company headquartered in Guangzhou, China, focusing on advanced cell line engineering and gene editing technologies. The company utilizes its proprietary CRISPR/Cas9 platform to offer comprehensive CRO services, including the creation of knockout, knock-in, and point-mutation cell lines for global research institutions and pharmaceutical companies. Beyond gene editing, Haixing Bio-Tech develops and commercializes high-performance cell culture media and reagents designed to optimize the growth of various mammalian cell types. Their services and products are integral to functional genomics, drug target discovery, and the development of biologics. By providing high-quality, customized cellular models, the company accelerates the R&D timelines for its partners in the life sciences sector.